Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
US11243214B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 21, 2017 |
| Grant date | Feb 8, 2022 |
| Priority date | — |
| Expiry date | May 31, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/042
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.